Shuttle Pharmaceuticals Holdings Inc (SHPH) Stock: Analyzing the Market Value

The 36-month beta value for SHPH is at 1.15.

The public float for SHPH is 9.42M, and currently, shorts hold a 0.40% of that float. The average trading volume for SHPH on June 13, 2024 was 59.66K shares.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

SHPH) stock’s latest price update

Shuttle Pharmaceuticals Holdings Inc (NASDAQ: SHPH)’s stock price has dropped by -5.19 in relation to previous closing price of 0.44. Nevertheless, the company has seen a loss of -18.43% in its stock price over the last five trading days. reported 2024-05-22 that GAITHERSBURG, Md., May 22, 2024 (GLOBE NEWSWIRE) — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT), today announced that Dr. Anatoly Dritschilo, Chief Executive Officer, will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2024 Investor Conference, taking place virtually on Thursday, May 30, 2024.

SHPH’s Market Performance

Shuttle Pharmaceuticals Holdings Inc (SHPH) has experienced a -18.43% fall in stock performance for the past week, with a 4.87% rise in the past month, and a -1.27% drop in the past quarter. The volatility ratio for the week is 12.84%, and the volatility levels for the past 30 days are at 11.81% for SHPH. The simple moving average for the past 20 days is -8.64% for SHPH’s stock, with a -13.28% simple moving average for the past 200 days.

SHPH Trading at -2.50% from the 50-Day Moving Average

After a stumble in the market that brought SHPH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -66.96% of loss for the given period.

Volatility was left at 11.81%, however, over the last 30 days, the volatility rate increased by 12.84%, as shares surge +1.35% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -4.20% lower at present.

During the last 5 trading sessions, SHPH fell by -18.43%, which changed the moving average for the period of 200-days by -40.49% in comparison to the 20-day moving average, which settled at $0.4596. In addition, Shuttle Pharmaceuticals Holdings Inc saw -7.78% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at SHPH starting from Jacobs Bette, who sale 4,157 shares at the price of $0.46 back on Dec 13 ’23. After this action, Jacobs Bette now owns 27,064 shares of Shuttle Pharmaceuticals Holdings Inc, valued at $1,926 using the latest closing price.

Brown Milton, the Director of Shuttle Pharmaceuticals Holdings Inc, sale 2,921 shares at $0.46 during a trade that took place back on Dec 13 ’23, which means that Brown Milton is holding 1,094,610 shares at $1,353 based on the most recent closing price.

Stock Fundamentals for SHPH

Current profitability levels for the company are sitting at:

  • -593.67 for the present operating margin
  • 0.25 for the gross margin

The net margin for Shuttle Pharmaceuticals Holdings Inc stands at -761.05. The total capital return value is set at -1.76. Equity return is now at value -152.02, with -96.75 for asset returns.

Based on Shuttle Pharmaceuticals Holdings Inc (SHPH), the company’s capital structure generated 0.32 points at debt to capital in total, while cash flow to debt ratio is standing at -4.27. The debt to equity ratio resting at 0.47. The interest coverage ratio of the stock is -2.4.

Currently, EBITDA for the company is -5.89 million with net debt to EBITDA at 0.02. When we switch over and look at the enterprise to sales, we see a ratio of 718.01. The receivables turnover for the company is 0.81for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.91.


In conclusion, Shuttle Pharmaceuticals Holdings Inc (SHPH) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts